AMELIA PITHA: Open Payments
NPI 1275179137 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 16 payments from 11 companies in 2025. Trend: 2023 $278 · 2024 $585 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| SCPHARMACEUTICALS INC. | 1 | $45 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 1 | $27 |
| Boston Scientific Corporation | 1 | $24 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Recor Medical Inc | 1 | $19 |
Products named: VERQUVO, LEQVIO, FUROSCIX, Attruby, VYNDAQEL, CAPVAXIVE, Wegovy, WATCHMAN Access System.
Industry payments across VA — which companies pay providers there.
